The evaluation of gamma-gluamylcyclotransferase as a novel target for cancer therapy and diagnosis
Researchers
- Emeritus Professor Philip Board (Primary Investigator)
Grant status
CompletedGrant start date
01/01/2009Grant funding
- 2009: $138,875 from National Health and Medical Research Council (NHMRC)
- 2010: $138,875 from National Health and Medical Research Council (NHMRC)
- 2011: $138,875 from National Health and Medical Research Council (NHMRC)
